Bayer: Up To $2.45 Billion Perfuse Therapeutics Acquisition Expands Ophthalmology Pipeline - Pulse 2.0
Bayer: Up To $2.45 Billion Perfuse Therapeutics Acquisition Expands Ophthalmology Pipeline Pulse 2.0
ORIGINAL SOURCE →via M&A News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · energy
- [ENERGY] Saudi Aramco’s $373mln supercomputer to boost upstream operations
- [ENERGY] Tight gas supply drives 27% jump in coal shipments to Japan, Korea and the EU
- [ENERGY] Shell Delivers Strong First Quarter Results
- [ENERGY] Water Is Quietly Becoming One of the Biggest Risks in Energy
- [ENERGY] Automate MongoDB Exports, Imports, and Sync Jobs with VisuaLeaf
- [ENERGY] Hochul announces billion-dollar energy rebates